ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

QLGN Qualigen Therapeutics Inc

0.286
-0.0043 (-1.48%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Qualigen Therapeutics Inc QLGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0043 -1.48% 0.286 14:00:04
Open Price Low Price High Price Close Price Previous Close
0.2914 0.2737 0.334 0.301 0.2903
more quote information »

Recent News

Date Time Source Heading
16/4/202421:00GLOBEMarizyme Enters Into Co-Development Agreement With Qualigen..
10/4/202422:00GLOBEQualigen Therapeutics' Novel Direct Pan-RAS Inhibitors..
09/4/202422:00GLOBEQualigen Therapeutics Announces Poster Featuring Positive..
27/2/202423:00EDGAR2Form 8-K - Current report
23/2/202408:10EDGAR2Form 8-K - Current report
08/12/202308:15EDGAR2Form 8-K - Current report
23/11/202308:30EDGAR2Form 8-K - Current report
15/11/202308:30GLOBEQualigen Therapeutics Provides Corporate Update for Third..
09/11/202306:16EDGAR2Form 8-K - Current report
08/11/202300:30GLOBEQualigen Therapeutics Announces First Patient Dosed in the..
23/10/202323:30GLOBEPoster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor..
17/10/202323:30EDGAR2Form 8-K - Current report
29/9/202306:15EDGAR2Form 8-K - Current report
27/9/202322:30GLOBEQualigen Therapeutics Presents Scientific Data on QN-302 at..
08/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
02/9/202306:15EDGAR2Form POS AM - Post-Effective amendments for registration..
17/8/202322:30GLOBEQualigen Therapeutics Partners with TD2 for Phase 1 Clinical..
16/8/202300:04EDGAR2Form 8-K - Current report
15/8/202322:30GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
15/8/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202306:30EDGAR2Form 8-K - Current report
01/8/202322:35EDGAR2Form 8-K - Current report
01/8/202322:30GLOBEQualigen Therapeutics Announces US FDA IND Clearance to..
27/7/202307:25EDGAR2Form 8-K - Current report
24/7/202322:15GLOBEQualigen Therapeutics Divests FastPack® Diagnostics Business
14/7/202307:29EDGAR2Form 8-K - Current report
08/7/202307:08EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
05/6/202322:15GLOBEPoster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor..
16/5/202322:00GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..

Your Recent History

Delayed Upgrade Clock